INFLUENCE OF SEX ON PLATELET RESPONSE TO ASPIRIN AND TICAGRELOR
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)33412-5
Abstract: Background: Aspirin's benefits for prevention of coronary artery disease differs by sex. While aspirin equally suppresses its target COX-1 in both sexes, platelets in women treated with aspirin retain greater platelet reactivity to COX-1-independent agonists… read more here.
Keywords: influence sex; sex platelet; platelet response; platelet ... See more keywords
GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy
Sign Up to like & getrecommendations! Published in 2021 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehab724.1425
Abstract: Aspirin and a potent platelet P2Y12 inhibitor, such as prasugrel or ticagrelor, are not always sufficient to prevent thrombus formation in patients with ST-elevation MI (STEMI), leading to “slow flow” or “no reflow” effects after… read more here.
Keywords: glenzocimab; aspirin ticagrelor; gpvi; atherosclerotic plaque ... See more keywords